Date	Period	Revenue/Estimate	Earnings Call
Aug 7, 2024	2025/Q1	2.403B / --	--
Feb 9, 2024	2024/Q3	2.437B / --	--
Aug 8, 2023	2024/Q1	1.701B / --	--
Feb 9, 2023	2023/Q3	1.749B / --	--
Aug 8, 2022	2023/Q1	1.056B / --	--

DatePeriodRevenue/EstimateEarnings Call

Aug 7, 20242025/Q12.403B / ----

Feb 9, 20242024/Q32.437B / ----

Aug 8, 20232024/Q11.701B / ----

Feb 9, 20232023/Q31.749B / ----

Aug 8, 20222023/Q11.056B / ----

Unlock Free Earnings Estimates

Open Account

KOKUSAI Earnings Reports

KOKUSAI: Half Year Report - Term 56 (2024/04/01 - 2025/03/31)

Nov 11, 2024 01:00 ET

KOKUSAI: Confirmation letter

Nov 11, 2024 01:00 ET

KOKUSAI: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)

Nov 8, 2024 02:00 ET

KOKUSAI: Notice regarding revisions to consolidated earnings forecasts and full-year consolidated earnings forecasts for the second quarter (interim period) of the fiscal year ending March 31, 2025

Nov 5, 2024 02:00 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.